332 related articles for article (PubMed ID: 33919750)
1. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers.
Zidi O; Souai N; Raies H; Ben Ayed F; Mezlini A; Mezrioui S; Tranchida F; Sabatier JM; Mosbah A; Cherif A; Shintu L; Kouidhi S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919750
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
[TBL] [Abstract][Full Text] [Related]
3. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
4. Metabolic fingerprinting in breast cancer stages through
Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
[TBL] [Abstract][Full Text] [Related]
5. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
6.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.
Wei S; Liu L; Zhang J; Bowers J; Gowda GA; Seeger H; Fehm T; Neubauer HJ; Vogel U; Clare SE; Raftery D
Mol Oncol; 2013 Jun; 7(3):297-307. PubMed ID: 23142658
[TBL] [Abstract][Full Text] [Related]
8. NMR-based metabonomic approach reveals changes in the urinary and fecal metabolome caused by resveratrol.
Torres Santiago G; Serrano Contreras JI; Meléndez Camargo ME; Zepeda Vallejo LG
J Pharm Biomed Anal; 2019 Jan; 162():234-241. PubMed ID: 30268024
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
10. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
[TBL] [Abstract][Full Text] [Related]
11. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.
Choi JS; Baek HM; Kim S; Kim MJ; Youk JH; Moon HJ; Kim EK; Nam YK
PLoS One; 2013; 8(12):e83866. PubMed ID: 24367616
[TBL] [Abstract][Full Text] [Related]
13. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
14. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.
Wang C; Peng J; Kuang Y; Zhang J; Dai L
Mol Med Rep; 2017 Aug; 16(2):1147-1156. PubMed ID: 28627685
[TBL] [Abstract][Full Text] [Related]
16. 1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients.
Singh A; Sharma RK; Chagtoo M; Agarwal G; George N; Sinha N; Godbole MM
PLoS One; 2017; 12(1):e0169330. PubMed ID: 28072864
[TBL] [Abstract][Full Text] [Related]
17. Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Richard V; Conotte R; Mayne D; Colet JM
Oncotarget; 2017 Jul; 8(30):49915-49930. PubMed ID: 28611296
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
19.
Kostidis S; Kokova D; Dementeva N; Saltykova IV; Kim HK; Choi YH; Mayboroda OA
BMC Infect Dis; 2017 Apr; 17(1):275. PubMed ID: 28412936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
